These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Conspicuous accumulation of membranous glomerulonephritis following gold therapy in chronic polyarthritis--a side effect of a new preparation?]. Burger HR, Briner J, Spycher MA. Schweiz Med Wochenschr; 1979 Mar 24; 109(12):423-31. PubMed ID: 106466 [Abstract] [Full Text] [Related]
3. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis. Bensen WG, Moore N, Tugwell P, D'Souza M, Singal DP. J Rheumatol; 1984 Jun 24; 11(3):358-61. PubMed ID: 6234391 [Abstract] [Full Text] [Related]
4. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate. Hull RG, Morgan SH, Parke AL, Childs L, Goldman M, Hughes GR. Int J Clin Pharmacol Res; 1984 Jun 24; 4(6):395-401. PubMed ID: 6442711 [Abstract] [Full Text] [Related]
5. Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions. Klinefelter. J Rheumatol; 1975 Mar 24; 2(1):21-7. PubMed ID: 127042 [Abstract] [Full Text] [Related]
10. [Gold therapy in chronic polyarthritis. Differentiation of allergic and toxic side effects]. Bene E, Megyeri A, Györi J. Z Rheumatol; 1980 Mar 24; 39(3-4):109-16. PubMed ID: 6448525 [Abstract] [Full Text] [Related]
11. Gold therapy in rheumatoid arthritis. Majoos FL, Klemp P, Meyers OL, Briggs B. S Afr Med J; 1981 Jun 27; 59(27):971-4. PubMed ID: 6787722 [Abstract] [Full Text] [Related]
12. Light- and electron-microscopical study of a case of gold salt-induced hepatotoxicity. Fleischner GM, Morecki R, Hanaichi T, Hayashi H, Quintana N, Sternlieb I. Hepatology; 1991 Sep 27; 14(3):422-5. PubMed ID: 1908434 [Abstract] [Full Text] [Related]